中东和非洲分子诊断市场预测至 2030 年 - 区域分析 - 按疾病领域(肿瘤、传染病、基因检测、心脏病、免疫系统疾病等)、技术(聚合酶链式反应、等温核酸扩增技术、DNA)测序和下一代测序、DNA 微阵列、原位杂交等)、产品和服务(检测和试剂盒、仪器以及服务和软件)以及最终用户(医院和诊所、诊断实验室、研究和学术机构) , 和别的)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 120    |    Report Code: TIPRE00026716    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Molecular Diagnostics Market

中东和中东地区非洲分子诊断市场预计将从2022年的8.2509亿美元增长到2030年的15.3225亿美元。预计2022年至2030年复合年增长率为8.0%。

个性化医疗中的分子诊断推动了中东和中东地区的发展非洲分子诊断市场

随着高通量技术的进步,基因组研究变得更加方便和具有成本效益。分子诊断在临床实验室中变得越来越不可或缺,因为这些试剂盒和测试可提供快速的检测结果,而传统测试在某些情况下还涉及在实验室条件下培养微生物。使用精准医学,根据每位患者独特的基因组成、生活方式和环境,为其量身定制医疗治疗和干预措施。分子诊断在这种方法中发挥着重要作用,因为它能够识别影响患者治疗相关决策的特定生物标志物、基因突变和基因表达模式。药物开发越来越依赖于分子诊断。广泛的分子成像技术用于筛查、检测、诊断、治疗和评估异质性;制定进步计划;检查分子特征;并监测患者的治疗结果。此外,分子成像可以帮助检测微小肿瘤并评估其活动,为肿瘤学个性化医疗、研究、临床试验和医疗实践的发展和扩展做出重大贡献。高通量基因分型平台可用于检测临床样本中的遗传畸变,下一代测序可用于识别所有类型的致癌变化。将这些技术引入临床实践将能够识别每个患者的分子靶标,并有助于跟踪疾病的分子进展。通过这些方法,癌症患者将能够接受个性化医疗。因此,随着技术的不断发展,分子诊断市场似乎有着光明的前景。

中东和中东地区非洲分子诊断市场概况

阿联酋、沙特阿拉伯、南非是中东和非洲主要国家。非洲。 2022年,沙特阿拉伯在区域分子诊断市场中占据最大份额。由于心血管疾病、糖尿病、胃肠道疾病和呼吸系统疾病等各种慢性病的患病率不断上升,以及政府在资金和医疗保健相关政策方面的举措不断增加,预计非洲将在 2022 年至 2030 年实现增长。

< p>

中东和中东地区非洲分子诊断市场收入及 2030 年预测(百万美元)

中东和非洲非洲分子诊断市场细分

 

中东和非洲非洲分子诊断市场分为疾病领域、技术、产品和服务、最终用户和国家。

根据疾病领域,中东和非洲地区是非洲分子诊断市场的重要组成部分。非洲分子诊断市场分为传染病、肿瘤学、基因检测、心脏病、免疫系统疾病等。传染病领域在中东和非洲地区登记最多。 2022 年非洲分子诊断市场份额。

基于技术,中东和非洲地区分子诊断市场份额非洲分子诊断市场分为聚合酶链反应(PCR)、原位杂交、等温核酸扩增技术(INAAT)、DNA测序和下一代测序(NGS)、DNA微阵列等。聚合酶链式反应 (PCR) 领域在中东和非洲地区注册最多。 2022 年非洲分子诊断市场份额。聚合酶链式反应 (PCR) 进一步细分为 RT-PCR、qPCR、多重 PCR 等。

根据产品和服务,中东和非洲地区预计将在 2022 年实现非洲分子诊断市场份额增长。非洲分子诊断市场分为检测和试剂盒、仪器、服务和软件。检测和试剂盒领域在中东和非洲地区注册最多。 2022 年非洲分子诊断市场份额。

根据最终用户,中东和非洲地区非洲分子诊断市场分为诊断实验室、医院和诊所、研究和学术机构等。诊断实验室领域拥有中东和非洲最大的市场。 2022 年非洲分子诊断市场份额。

基于国家、中东和非洲地区非洲分子诊断市场分为阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区。非洲。沙特阿拉伯主导了中东和中东地区。 2022 年非洲分子诊断市场。

Abbott Laboratories、bioMerieux SA、Danaher、F. Hoffmann-La Roche Ltd、Illumina Inc、Novartis AG、Qiagen NV、Siemens Healthineers AG 和 Thermo Fisher Scientific Inc是一些在中东和中东地区运营的领先公司。非洲分子诊断市场。



Middle East & Africa Molecular Diagnostics Strategic Insights

Strategic insights for Middle East & Africa Molecular Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-molecular-diagnostics-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Molecular Diagnostics Report Scope

Report Attribute Details
Market size in 2022 US$ 825.09 Million
Market Size by 2030 US$ 1,532.25 Million
Global CAGR (2022 - 2030) 8.0%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 疾病领域
  • 肿瘤
  • 传染病
  • 基因检测
  • 心脏疾病
  • 免疫系统疾病
By 技术
  • 聚合酶链式反应
  • 等温核酸扩增技术
  • DNA测序和下一代测序
  • DNA微阵列
  • 原位杂交
By 产品和服务
  • 检测试剂盒
  • 仪器
  • 服务和软件
By 最终用户
  • 医院和诊所
  • 诊断实验室
  • 研究和学术机构
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Abbott Laboratories
  • bioMerieux SA
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Novartis AG
  • Qiagen NV
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
  • Get more information on this report

    Middle East & Africa Molecular Diagnostics Regional Insights

    The regional scope of Middle East & Africa Molecular Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-molecular-diagnostics-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Molecular Diagnostics Market

    1. Abbott Laboratories
    2. bioMerieux SA
    3. Danaher
    4. F. Hoffmann-La Roche Ltd
    5. Illumina Inc
    6. Novartis AG
    7. Qiagen NV
    8. Siemens Healthineers AG
    9. Thermo Fisher Scientific Inc
    Frequently Asked Questions
    How big is the Middle East & Africa Molecular Diagnostics Market?

    The Middle East & Africa Molecular Diagnostics Market is valued at US$ 825.09 Million in 2022, it is projected to reach US$ 1,532.25 Million by 2030.

    What is the CAGR for Middle East & Africa Molecular Diagnostics Market by (2022 - 2030)?

    As per our report Middle East & Africa Molecular Diagnostics Market, the market size is valued at US$ 825.09 Million in 2022, projecting it to reach US$ 1,532.25 Million by 2030. This translates to a CAGR of approximately 8.0% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Molecular Diagnostics Market report typically cover these key segments-

  • 疾病领域 (肿瘤, 传染病, 基因检测, 心脏疾病, 免疫系统疾病)
  • 技术 (聚合酶链式反应, 等温核酸扩增技术, DNA测序和下一代测序, DNA微阵列, 原位杂交)
  • 产品和服务 (检测试剂盒, 仪器, 服务和软件)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Molecular Diagnostics Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Molecular Diagnostics Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Middle East & Africa Molecular Diagnostics Market?

    The Middle East & Africa Molecular Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott Laboratories
  • bioMerieux SA
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Illumina Inc
  • Novartis AG
  • Qiagen NV
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
  • Who should buy this report?

    The Middle East & Africa Molecular Diagnostics Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Molecular Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.